Lowering serum uric acid levels:: What is the optimal target for improving clinical outcomes in gout?

被引：119

作者：

Perez-Ruiz, Fernando

Liote, Frederic

机构：

[1] Assistance Publ Hop Paris, INSERM, Ctr Rhumatol Viggo Petersen, Hop Lariboisiere,U606,IFR 139, F-75010 Paris, France

[2] Univ Med Paris 7 Denis Diderot, Paris, France

[3] Hosp Cruces, Baracaldo, Pais Vasco, Spain

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2007年 / 57卷 / 07期

关键词：

D O I：

10.1002/art.23007

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：1324 / 1328

页数：5

共 37 条

[1]

Arromdee E, 2002, J RHEUMATOL, V29, P2403

[2]

Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].

Becker, MA ;

Schumacher, HR ;

Wortmann, RL ;

MacDonald, PA ;

Eustace, D ;

Palo, WA ;

Streit, J ;

Joseph-Ridge, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461

[3]

Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase [J].

Becker, Michael A. ;

Schumacher, H. Ralph, Jr. ;

Wortmann, Robert L. ;

MacDonald, Patricia A. ;

Palo, William A. ;

Eustace, Denise ;

Vernillet, Laurent ;

Joseph-Ridge, Nancy .

ARTHRITIS AND RHEUMATISM, 2005, 52 (03) :916-923

[4]

Borstad GC, 2004, J RHEUMATOL, V31, P2429

[5]

STUDIES ON NATURE OF GOUTY TOPHI - INFLAMMATORY RESPONSE TO INJECTED SODIUM URATE 1899 [J].

BRILL, JM ;

MCCARTY, DJ .

ANNALS OF INTERNAL MEDICINE, 1964, 60 (03) :486-+

[6]

Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4

[7]

Darmawan J, 2003, J RHEUMATOL, V30, P2437

[8]

EFFECTS OF ALLOPURINOL A XANTHINE OXIDASE INHIBITOR AND SULFINPYRAZONE UPON URINARY AND SERUM URATE CONCENTRATIONS IN 8 PATIENTS WITH TOPHACEOUS GOUT [J].

GOLDFARB, E ;

SMYTH, CJ .

ARTHRITIS AND RHEUMATISM, 1966, 9 (03) :414-&

[9]

PREVALENCE AND PROPHYLAXIS OF GOUT IN ENGLAND [J].

HARRIS, CM ;

LLOYD, DCEF ;

LEWIS, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (09) :1153-1158

[10]

HOCHBERG MC, 2004, PRACTICAL RHEUMATOLO

← 1 2 3 4 →